# Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

> **NCT06185361** · NA · UNKNOWN · sponsor: **Fayoum University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Nocturnal Enuresis
- Enuresis
- Enuresis, Nocturnal

## Interventions

- **DRUG:** Fluoxetine 20 MG
- **DRUG:** Desmopressin

## Key facts

- **NCT ID:** NCT06185361
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185361, "Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06185361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*